Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy

Sweeney, CJ; Martin, AJ; Stockler, MR; Begbie, S; Chi, KN; Chowdhury, S; Coskinas, X; Frydenberg, M; Hague, WE; Horvath, LG; Joshua, AM; Lawrence, NJ; Marx, GM; McCaffrey, J; McDermott, R; McJannett, M; North, SA; Parnis, F; Parulekar, W; Pook, DW; Reaume, MN; Sandhu, SK; Tan, A; Tan, TH; Thomson, A; Tu, E; Vera-Badillo, F; Williams, SG; Yip, S; Zhang, AY; Zielinski, RR; Davis, ID

Sweeney, CJ (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,DA917, Boston, MA 02215 USA.

EUROPEAN UROLOGY, 2021; 80 (3): 275

Abstract

Men who initially present with localized prostate cancer and later develop metachro-nous metastases have a better prognosis than men with de novo meta......

Full Text Link